The FDA Just Launched Operation TrialBlazer: Is Your Clinical Trial Archive Ready to Keep Up? As digital clinical research continues to evolve, pharmaceutical organizations must consider how electronic records are governed and controlled. Operation TrialBlazer is focused on accelerating clinical development, making modern information-management infrastructure increasingly important.
What Is 21 CFR Part 11?
21 CFR Part 11 establishes FDA requirements for electronic records and electronic signatures in certain regulated contexts.
Why Does Part 11 Matter to Clinical Research?
Clinical organizations increasingly depend on electronic systems to create, manage, and retain information.
What Should Organizations Consider When Archiving Electronic Records?
Organizations should assess:
- Data integrity
- Access controls
- Audit trails
- Record authenticity
- Security
- Retention
- Retrieval
How Can Archiving Support Electronic Records Management?
A governed archive can provide controlled long-term access to electronic records.
Why Is Auditability Important?
Organizations need confidence that archived information remains trustworthy and appropriately controlled.
How Should Companies Evaluate Archive Platforms?
They should assess technical capabilities against their specific regulatory and validation requirements rather than assuming that every archive automatically satisfies Part 11.
How Can Solix Help?
Solix provides enterprise archiving and lifecycle management capabilities that can be evaluated as part of a pharmaceutical organization's electronic-records strategy.
Frequently Asked Questions
What is 21 CFR Part 11?
It is an FDA regulation covering electronic records and electronic signatures in applicable regulated environments.
Does every archive automatically meet Part 11?
No. Organizations need to evaluate the specific system, configuration, controls, validation, and intended use